Advanced search
Start date
Betweenand


Poly I:C elicits broader and stronger humoral and cellular responses to a Plasmodium vivax circumsporozoite protein malaria vaccine than Alhydrogel in mice

Full text
Author(s):
Show less -
Costa-Gouvea, Tiffany B. L. ; Francoso, Katia S. ; Marques, Rodolfo F. ; Gimenez, Alba Marina ; Faria, Ana C. M. ; Cariste, Leonardo M. ; Dominguez, Mariana R. ; Vasconcelos, Jose Ronnie C. ; Nakaya, Helder I. ; Silveira, Eduardo L. V. ; Soares, Irene S.
Total Authors: 11
Document type: Journal article
Source: FRONTIERS IN IMMUNOLOGY; v. 15, p. 15-pg., 2024-04-08.
Abstract

Malaria remains a global health challenge, necessitating the development of effective vaccines. The RTS,S vaccination prevents Plasmodium falciparum (Pf) malaria but is ineffective against Plasmodium vivax (Pv) disease. Herein, we evaluated the murine immunogenicity of a recombinant PvCSP incorporating prevalent polymorphisms, adjuvanted with Alhydrogel or Poly I:C. Both formulations induced prolonged IgG responses, with IgG1 dominance by the Alhydrogel group and high titers of all IgG isotypes by the Poly I:C counterpart. Poly I:C-adjuvanted vaccination increased splenic plasma cells, terminally-differentiated memory cells (MBCs), and precursors relative to the Alhydrogel-combined immunization. Splenic B-cells from Poly I:C-vaccinated mice revealed an antibody-secreting cell- and MBC-differentiating gene expression profile. Biological processes such as antibody folding and secretion were highlighted by the Poly I:C-adjuvanted vaccination. These findings underscore the potential of Poly I:C to strengthen immune responses against Pv malaria. (AU)

FAPESP's process: 19/06494-1 - Comparative analysis between the humoral and cellular immune responses elicited by a malaria vaccine adjuvanted with poly I:C or alum in C57BL/6 mice
Grantee:Tiffany Bianca Lage da Costa
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 14/18102-7 - Preclinical tests of recombinant adenovirus-based protein and vaccine formulations expressing the Plasmodium vivax circumsporozoite protein
Grantee:Alba Marina Gimenez
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 18/14933-2 - Integrative biology applied to human health
Grantee:Helder Takashi Imoto Nakaya
Support Opportunities: Research Grants - Young Investigators Grants - Phase 2
FAPESP's process: 17/11931-6 - Identification of B cell protective antigens/epitopes against asexual and sexual blood forms of Plasmodium parasites through monoclonal antibodies
Grantee:Eduardo Lani Volpe da Silveira
Support Opportunities: Regular Research Grants
FAPESP's process: 19/25373-0 - Influence of the proteic-energetic malnutrution in the humoral e cellular immune responses elicited by a malaria vaccine in C57Bl/6 mice
Grantee:Ana Carolina Machado de Faria
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 12/13032-5 - Generation and analysis of the immunogenicity of recombinant proteins based on the different allelic forms of the circumsporozoite antigen of Plasmodium vivax aiming at the development of a universal vaccine against malaria
Grantee:Irene da Silva Soares
Support Opportunities: Research Projects - Thematic Grants